Sheridan Gray Snyder OBE (born October 20, 1936) is an entrepreneur, venture capitalist, and philanthropist[2]: 6 [3] in the biotechnology industry.
[3][5] In its earliest moments "Genzyme was just really the combination" of Snyder and Henry Blair, a technician at the New England Enzyme Center at Tufts Medical School,[7] who had worked for Roscoe Brady at the National Institute of Health (NIH).
[8] By 1983 Genzyme interviewed Baxter employee Henri Termeer, who had completed his MBA at Snyder's alma mater, the University of Virginia in 1973.
These "well-known, full professors who had a lot of multidisciplinary post-docs" had formed a successful Boston-based business management consulting firm a Bio Information Associates (BIA) in 1980.
[11] "In the formative years of biotechnology, Genzyme was the industry’s Apple, blazing a pathway for creating protein-based treatments for rare diseases.
In 1996, Snyder founded and served as chairman and chief executive officer of Upstate Biotechnology Incorporated, merging it with Argonex.
[1][16] In 2005 the Ivy Charitable Foundation donated "$45 million to the University of Virginia Health System to expand laboratory space for biomedical research and to speed the translation of new discoveries into effective treatments and cures.
[16][17] Snyder funded and developed the National Junior Tennis League (NJTL),[6] along with the encouragement and support of Arthur Ashe and Charles Pasarell.
In 1988, Snyder was the founder, chairman and CEO of Compuflo Inc., which developed a specialty high-end computer program used to analyze airflow to aid the design of aircraft and autos, a company donated to the University of Virginia to support its laboratories.